Moderna has rallied ~23%, but I maintain a 'Sell' and 'market underperform' rating due to deteriorating fundamentals. MRNA’s recent rally is driven by improved liquidity, cost discipline, and a $1.5 ...

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups could help fill the void after the Trump administration slashed federal ...

Here's your look at the Zlín City: Arch Moderna announcement trailer for this upcoming cozy, historically inspired city-builder. Join developer Polyperfect for a behind-the-scenes look at the creation ...

Nov 20 (Reuters) - Moderna (MRNA.O), opens new tab said on Thursday it secured a five-year loan of $1.5 billion from Ares Management (ARES.N), opens new tab, as it targets up to 10% revenue growth ...

Moderna Inc. said it had secured a loan for up to $1.5 billion, a move aimed at shoring up the company’s finances as it struggles with the decline of its COVID business. The five-year loan facility ...

CAMBRIDGE, MA / ACCESS Newswire / November 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced the expansion of its U.S. manufacturing capabilities with the onshoring of Drug Product manufacturing ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Moderna is investing more than ...

A recent deep dive into the unraveling of Moderna by reporter Jason Mast is one of the most popular STAT stories of the year. STAT’s 2016 story on one of “biotech’s most secretive startups,” by ...

Moderna Inc. shares rose after the company posted a narrower third-quarter loss than Wall Street expected, a sign that its cost-cutting measures are helping offset the decline of its Covid business.

Mast interviewed more than two dozen former and current Moderna employees, along with analysts, rival executives, investors, and experts in mRNA and vaccines to understand how the company arrived at ...

Moderna Inc (NASDAQ:MRNA) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc ...

Scientists used IBM's R2 Heron quantum processor to predict the secondary protein structure of a 60-nucleotide-long mRNA sequence. When you purchase through links on our site, we may earn an affiliate ...